Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes

BACKGROUND: Onchocerciasis is found predominantly in Africa where large scale vector control started in 1974. Registration and donation of ivermectin by Merck & Co in 1987 enabled mass treatment with ivermectin in all endemic countries in Africa and the Americas. Although elimination of onchocer...

Descripción completa

Detalles Bibliográficos
Autores principales: Dadzie, Yankum, Amazigo, Uche V., Boatin, Boakye A., Sékétéli, Azodoga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029117/
https://www.ncbi.nlm.nih.gov/pubmed/29966535
http://dx.doi.org/10.1186/s40249-018-0446-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029117/
https://www.ncbi.nlm.nih.gov/pubmed/29966535
http://dx.doi.org/10.1186/s40249-018-0446-z

Ejemplares similares